. . . . . . . "[Challenge experiments showed that co-administration of pVAX-IL-21-IL-15 and pVAX-CDPK1 significantly (P < 0.05) increased survival time (19.2 � 5.1 days) compared with pVAX-CDPK1 (17.3 � 4.3 days) or pVAX-IL-21-IL-15 (12.0 � 2.0 days) alone, and pVAX-IL-21-IL-15 +?pVAX-CDPK1 significantly reduced the number of brain cysts (72.7%) in contrast to pVAX-ROP13 (45.7%) or pVAX-IL-21-IL-15 alone (43.6%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:18:47+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .